Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cells
Open Access
- 31 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 90 (3) , 457-463
Abstract
Tissue-type plasminogen activator (t-PA) is produced by endothelial cells (EC) and is responsible for the removal of intravascular fibrin deposits. We investigated whether expression of t-PA by EC is under epigenetic control. Methylation analysis of the proximal t-PA promoter revealed a stretch of unmethylated CpG dinucleotides from position −121 to +59, while upstream CpG dinucleotides were all methylated. In contrast, in human primary hepatocytes, which express t-PA at much lower levels than EC, the proximal promoter was partially methylated. Treatment of EC with the non-specific histone deacetylase (HDAC) inhibitors butyrate and trichostatin and with MS275, a specific inhibitor of class I HDAC, resulted in a time- and dose-dependent increase in t-PA expression. Garcinol and anacardic acid, inhibitors of the histone acetyl transferases CBP/p300 and PCAF, reduced basal and HDAC inhibitor-induced t-PA expression, whereas curcumin, an inhibitor of CBP/p300 only, had no effect. We performed chromosome immunoprecipitation analysis of the t-PA promoter using antibodies specific for acetylated histone H3 or H4 and observed an increase in H3 acetylation of 10 ± 3 and 44 ± 14-fold in EC treated with trichostatin or MS275, respectively, and in H4 acetylation of 7.7 ± 1.4 and 16 ± 3-fold, respectively. The proximal t-PA promoter is unmethylated in human EC and partially methylated in human primary hepatocytes. Expression of t-PA by EC is repressed by HDACs in a mechanism that involves de-acetylation of histone H3 and H4.Keywords
This publication has 24 references indexed in Scilit:
- Epigenetics of the vascular endotheliumJournal of Applied Physiology, 2010
- Epigenetic Regulation of the Cardiovascular SystemCirculation Research, 2010
- Epigenetics and cardiovascular diseaseNature Reviews Cardiology, 2010
- Epigenetic tools in potential anticancer therapyAnti-Cancer Drugs, 2010
- Pharmacology of epigenetics in brain disordersBritish Journal of Pharmacology, 2010
- Targeting tumor angiogenesis with histone deacetylase inhibitorsCancer Letters, 2009
- Histone deacetylase inhibitors: Potential in cancer therapyJournal of Cellular Biochemistry, 2009
- Linking DNA methylation and histone modification: patterns and paradigmsNature Reviews Genetics, 2009
- Quercetin induced tissue-type plasminogen activator expression is mediated through Sp1 and p38 mitogen-activated protein kinase in human endothelial cellsJournal of Thrombosis and Haemostasis, 2008
- Stimulation by Retinoids of Tissue-Type Plasminogen Activator Secretion in Cultured Human Endothelial CellsJournal of Cardiovascular Pharmacology, 1992